Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease (Q35190476)

7 August 2017

1 reference

title

Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease (English)

1 reference

7 August 2017

0 references

Keisei Kawa

1

1 reference

7 August 2017

publication date

1 July 2003

1 reference

International Journal of Hematology

7 August 2017

published in

1 reference

7 August 2017

volume

78

1 reference

7 August 2017

issue

1

1 reference

7 August 2017

page(s)

24-31

1 reference

Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02983236

CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02983236

Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02983236

Skin is the frequent site for involvement of peripheral T-cell and natural killer cell lymphomas in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02983236

Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02983236

Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02983236

Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02983236

p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02983236

Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02983236

EBV specific CTL: a model for immune therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02983236

Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02983236

Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay

21 January 2018

1 reference

12 December 2020

Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus

1 reference

12 December 2020

Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders

1 reference

12 December 2020

Extranodal peripheral T-cell and NK-cell neoplasms

1 reference

12 December 2020

Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2

1 reference

12 December 2020

Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage

1 reference

12 December 2020

Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

1 reference

12 December 2020

Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese

1 reference

12 December 2020

Clinical and virologic characteristics of chronic active Epstein-Barr virus infection

1 reference

12 December 2020

Lymphoproliferative disorders of natural killer cells

1 reference

12 December 2020

Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: High prevalence of p53 overexpression

1 reference

12 December 2020

Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells.

1 reference

12 December 2020

Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma

1 reference

12 December 2020

Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.

1 reference

12 December 2020

Classification of natural killer (NK) cell and NK-like T-cell malignancies

1 reference

12 December 2020

Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma

1 reference

12 December 2020

A possible mechanism of NK cell-lineage granular lymphocyte proliferative disorder (NK-GLPD) in a patient with chronic active Epstein-Barr virus infection (CAEBV) and severe hypersensitivity to mosquito bites (SHMB).

1 reference

12 December 2020

Diagnosis and management of primary nasal lymphoma of T-cell or NK-cell origin

1 reference

12 December 2020

The significance of granzyme B expression in patients with angiocentric lymphoma of the head and neck

1 reference

12 December 2020

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

1 reference

12 December 2020

Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation

1 reference

12 December 2020

Lymphomatous features of aggressive NK cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and EB virus infection

1 reference

12 December 2020

Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells

1 reference

12 December 2020

P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833.

1 reference

12 December 2020

Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognition.

1 reference

12 December 2020

Epstein-Barr virus--associated diseases in humans

1 reference

12 December 2020

L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation

1 reference

12 December 2020

Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas

1 reference

12 December 2020

Successful treatment of disseminated nasal NK/T-cell lymphoma using double autologous peripheral blood stem cell transplantation.

1 reference

12 December 2020

Successful allogeneic stem cell transplantation from an unrelated donor for aggressive Epstein-Barr virus-associated clonal T-cell proliferation with hemophagocytosis

1 reference

12 December 2020

A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma

1 reference

12 December 2020

Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukaemia

1 reference

12 December 2020

Epstein-Barr virus-infected natural killer cell leukemia

1 reference

12 December 2020

Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines.

1 reference

12 December 2020

Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site

1 reference

12 December 2020

1 reference

12 December 2020

Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.

1 reference

12 December 2020

Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design

1 reference

12 December 2020

Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease

1 reference

12 December 2020

Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2.

1 reference

12 December 2020

Analysis of chromosome 6q deletion in EBV-associated NK cell leukaemia/lymphoma

1 reference

12 December 2020

Expression of HLA class I, beta(2)-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK/T-cell lymphoma: Implications for tumor immune escape mechanism

1 reference

12 December 2020

Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease

1 reference

12 December 2020

Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor

1 reference

12 December 2020

Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line.

1 reference

12 December 2020

Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway

1 reference

12 December 2020

Mutations of the p53 gene in nasal NK/T-cell lymphoma

1 reference

12 December 2020

Nasal natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02983236

1 reference

7 August 2017

1 reference